MeiraGTx has announced that its AAV8-RK-RetGC program for the treatment of patients with Leber congenital amaurosis due to GUCY2D mutations (LCA1) has been granted Rare Pediatric Disease Designation (RPDD) by the FDA $MGTX biotuesdays.com/2025/01/22/fda…

IPA (ImmunoPrecise Antibodies) has announced the development of a new class of GLP-1 therapies—leveraging AI—to enhance the efficacy, safety, and longevity of treatments for Type 2 diabetes (T2D) and obesity $IPA biotuesdays.com/2025/01/22/ipa…

Veru has announced positive topline results from its Phase 2b QUALITY clinical study evaluating the safety and efficacy of enobosarm in patients receiving WEGOVY (semaglutide) for weight reduction $VERU biotuesdays.com/2025/01/27/ver…

RenovoRX highlights abstract showcasing promising PK data for TAMP in LAPC $RNXT biotuesdays.com/2025/01/27/ren…

Stereotaxis has announced that it has received European CE Mark approval for its MAGIC ablation catheter, designed to perform cardiac ablation procedures aimed at treating heart arrhythmia $STXS biotuesdays.com/2025/01/27/ste…

Conduit Pharmaceuticals has announced that the first phase in its collaboration with Sarborg, aimed at integrating advanced AI and cybernetics technology into its operations has been completed $CDT biotuesdays.com/2025/01/28/con…

NLS Pharmaceutics has announced the launch of a preclinical program to evaluate Mazindol ER as a novel treatment for fentanyl dependence $NLSP biotuesdays.com/2025/01/28/nls…

Polyrizon has announced the filing of a patent application for its advanced intranasal drug delivery system Trap & Target (T&T) technology, with the Israel Patent Office (ILPO) $PLRZ biotuesdays.com/2025/01/30/pol…

Tectonic Therapeutic has announced positive interim data from its Phase 1b acute hemodynamic clinical trial of TX45 in Group 2 Pulmonary Hypertension in Heart Failure with Preserved Ejection Fraction (“PH-HFpEF”) $TECX biotuesdays.com/2025/01/30/tec…

HOOKIPA Pharma has announced the completion of enrollment for its Phase 1b trial evaluating HB-500 in patients with HIV $HOOK biotuesdays.com/2025/01/30/hoo…

INBS upgrades portable drug screening reader with multilingual capabilities $INBS biotuesdays.com/2025/01/31/inb…

Tonix Pharmaceuticals has announced the appointment of Siobhan Fogarty as chief technical officer (CTO), effective immediately $TNXP biotuesdays.com/2025/02/04/ton…

Therma Bright has announced the appointment of Steve Raysely to its advisory board $TBRIF biotuesdays.com/2025/02/04/the…

In our latest #BioTuesdays feature, CEO Melissa Sherman, Ph.D., shares how MOBILion Systems, is redefining analytical characterization with next-gen separation science. biotuesdays.com/2025/02/04/mob…

New data from BioRestorative Therapies’ ongoing Phase 2 trial of cell-based BRTX-100 in cLDD potentially show disc microenvironment remodeling in addition to reported improvements in VAS and ODI $BRTX biotuesdays.com/2025/02/10/new…

Esko Bionics names National Seating & Mobility as exclusive distributor of Ekso Indego Personal device within the complex rehabilitation technology industry $EKSO biotuesdays.com/2025/02/10/esk…

Biodexa Pharmaceuticals has announced that eRapa, a form of rapamycin being developed for the treatment of familial adenomatous polyposis (FAP), has been granted Fast Track Designation by the FDA $BDRX biotuesdays.com/2025/02/10/fda…

Medicus Pharma announced that its SKNJCT-003 Phase 2 study, evaluating the efficacy of two dose levels of D-MNA for the treatment of nodular basal cell carcinoma (BCC), has now randomized more than 50% of the 60 patients targeted for enrollment $MDCX biotuesdays.com/2025/02/14/med…

Personalis spotlights new publication from ICR and Royal Marsden on ctDNA testing in MRD $PSNL biotuesdays.com/2025/03/03/per…

Stereotaxis has announced that it has submitted its robotically navigated catheter, EMAGIN 5F, for FDA regulatory clearance $STXS biotuesdays.com/2025/03/03/ste…